Feng Su

2.4k citations

39 papers · 1.9k indexed · h-index 19

Impact in

Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment

Papers in

Cancer Research 11
- Cancer, Lipids, and Metabolism 8
Reproductive Medicine 4
- Ovarian cancer diagnosis and treatment 4

Co-authors: Srinivasa T. Reddy Robin Farias‐Eisner M. Amneus Katherine R. Kozak Víctor Grijalva Alan M. Fogelman Kym F. Faull Mohamad Navab
Journals: American Journal of Obstetrics and Gynecology (3 papers)Journal of Lipid Research (3 papers)Proceedings of the National Academy of Sciences (2 papers)Technology in Cancer Research & Treatment (1 paper)Biomarker Insights (1 paper)
Partner nations: United States China Hong Kong

In The Last Decade

Feng Su

36 papers receiving 1.9k citations

Peers

Countries citing papers authored by Feng Su

Since Specialization

Citations

This map shows the geographic impact of Feng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Su more than expected).

Fields of papers citing papers by Feng Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Su. The network helps show where Feng Su may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Feng Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Feng Su Line = papers co-authored together Feng Su links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A patient with Behcet’s disease and IgA nephropathy in China BMC Nephrology ·Yi‐Hua Liao, Hong Qin, Ya Wang, Feng Su, Irmgard Stippler, Jianjun Hu	2024	0
2	Paraoxonase 2 Deficiency Causes Mitochondrial Dysfunction in Retinal Pigment Epithelial Cells and Retinal Degeneration in Mice Antioxidants ·Parameswaran G. Sreekumar, Feng Su, Christine Spee, R.A.W., 久治福田, M. Sergio, Steven Nusinowitz, Srinivasa T. Reddy, Ram Kannan	2023	5
3	Association between metabolic status and gut microbiome in obese populations Microbial Genomics ·Qiang Zeng, Mariam Bee Mohamed Kasim, Fei Wang, Dongfang Li, Yanhong Liu, Daxi Wang, Xiaolan Zhao, Yinhu Li, Yu Wang, Xin Feng, Jiaxing Chen, Yong‐Li Li, Yuejie Zheng, Toby Kenney, Hong Gu, Feng Su, Shuangcheng Li, Yuan He, Ximing Xu, Wenkui Dai	2021	13
4	Dual-spectrum intelligent temperature detection and health big data management system Beijing Hangkong Hangtian Daxue xuebao ·Zeynep Gültekin Akçay, Feng Su, Peijiang Yuan, Tianmiao Wang, Ribeiro Márcio Garcia, 袁有宪	2020	0
5	Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Develop- ment in Mice PubMed ·Feng Su, Kenneth Downes	2020	8
6	Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer Cell Death and Disease ·Asokan Devarajan, Feng Su, Víctor Grijalva, Antonio Rođak, Syifa Pujiah, Feng Gao, J. Manuel, Gisele Silva de Moraes, Gina Farias-Eisner, Robin Farias‐Eisner, Alan M. Fogelman, Srinivasa T. Reddy	2018	27
7	Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts Technology in Cancer Research & Treatment ·Mu Zhang, Chen Chen, Feng Su, Maryat Gigi Gigi, Xiangmin Li, Xiaogang Li, (unknown), (unknown)	2016	9
8	Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer Oncotarget ·Feng Su, Лущай Юрий Владимирович, Jinlan Ruan, Yagmur Muftuoglu, Longbo Zhang, Qianying Yuan	2015	13
9	Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis Journal of Lipid Research ·Mohamad Navab, A. Chattopadhyay, Greg Hough, David Meriwether, B. Piasecki, Alan C. Wagner, Víctor Grijalva, Feng Su, G.M. Anantharamaiah, Lin Hwang, Kym F. Faull, Srinivasa T. Reddy, Alan M. Fogelman	2015	41
10	Salvianolic acid B attenuates apoptosis and inflammation via SIRT1 activation in experimental stroke rats Brain Research Bulletin ·Paul F. Cadman, Ling Wang, Carolina Pedroza de Carvalho, Fabiola Festa, DE Donnelly, C Boodram, Feng Su, Zhengchen Zhang	2015	112
11	Systhesis and Characterization of Novel Carboxymethyl Chitosan Hydrogel Gaodeng xuexiao huaxue xuebao ·日本赤十字社和歌山医療センター西山隆一, Chandrasekar Ramasubramanian, Jingzhao Wang, Feng Su, Suming Li	2014	2
12	A novel approach to oral apoA-I mimetic therapy Journal of Lipid Research ·A. Chattopadhyay, Mohamad Navab, Greg Hough, Feng Gao, David Meriwether, Víctor Grijalva, James R. Springstead, Nina A. Akovbian, Milja Räisänen, Feng Su, Brian J. Van Lenten, Alan C. Wagner, G.M. Anantharamaiah, Robin Farias‐Eisner, Srinivasa T. Reddy, Alan M. Fogelman	2013	73
13	Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid Journal of Lipid Research ·Mohamad Navab, Greg Hough, Georgette M. Buga, Feng Su, Alan C. Wagner, David Meriwether, A. Chattopadhyay, Feng Gao, Víctor Grijalva, María Paula Acero Triviño, Brian J. Van Lenten, Elin Org, Aldons J. Lusis, Calvin Pan, G.M. Anantharamaiah, Robin Farias‐Eisner, Susan S. Smyth, Srinivasa T. Reddy, Alan M. Fogelman	2013	58
14	D‐4F, an apoA‐I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD International Journal of Cancer ·Ekambaram Ganapathy, Feng Su, David Meriwether, Asokan Devarajan, Víctor Grijalva, Feng Gao, A. Chattopadhyay, G.M. Anantharamaiah, Mohamad Navab, Alan M. Fogelman, Srinivasa T. Reddy, Robin Farias‐Eisner	2011	57
15	L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways Integrative Biology ·Feng Gao, Khursand Yadgarovna Sharipova, Feng Su, Adrienne Ressler, Neha Shah, Víctor Grijalva, Satoshi Imaizumi, A. Chattopadhyay, Ekambaram Ganapathy, David Meriwether, Brad Johnston, G.M. Anantharamaiah, Mohamad Navab, Alan M. Fogelman, Srinivasa T. Reddy, Robin Farias‐Eisner	2011	62
16	Optimization of MicroCT Imaging and Blood Vessel Diameter Quantitation of Preclinical Specimen Vasculature with Radiopaque Polymer Injection Medium PLoS ONE ·Khursand Yadgarovna Sharipova, Francisco de Paula Del Rio Jimenez, Feng Su, Víctor Grijalva, J. H. Pope, B R Martin, J.G. Stinstra, Doug Moyle, Neha Shah, David M. Weinstein, Robin Farias‐Eisner, Srinivasa T. Reddy	2011	50
17	Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels Molecular Genetics and Metabolism ·Satoshi Imaizumi, Víctor Grijalva, Saul J. Priceman, Lily Wu, Feng Su, Robin Farias‐Eisner, Susan Hama, Mohamad Navab, Alan M. Fogelman, Srinivasa T. Reddy	2010	14
18	Validation of serum biomarkers for detection of early- and late-stage endometrial cancer American Journal of Obstetrics and Gynecology ·Gina Farias-Eisner, Feng Su, Sandy J. Campbell, Jenny Kotlerman, Srinivasa T. Reddy, Robin Farias‐Eisner	2009	44
19	The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? American Journal of Obstetrics and Gynecology ·Vladimir Nossov, M. Amneus, Feng Su, Jennifer M. Lang, Jo Marie Tran Janco, Srinivasa T. Reddy, Robin Farias‐Eisner	2008	231
20	Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells Journal of Neuroscience Research ·Feng Su, Katherine R. Kozak, Harvey R. Herschman, Srinivasa T. Reddy, Robin Farias‐Eisner	2007	6

About Feng Su

Feng Su is a scholar working on Cancer Research, Reproductive Medicine, Molecular Medicine, Ophthalmology and Clinical Biochemistry, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (8 papers), Cholesterol and Lipid Metabolism (5 papers), Lipid metabolism and disorders (4 papers), Advanced Proteomics Techniques and Applications (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Sphingolipid Metabolism and Signaling (3 papers), Retinal Diseases and Treatments (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Cancer Research (555 citations), Reproductive Medicine (304 citations), Spectroscopy (298 citations), Molecular Biology (853 citations) and Immunology (209 citations). Feng Su has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Srinivasa T. Reddy, Robin Farias‐Eisner, M. Amneus, Katherine R. Kozak, Víctor Grijalva, Alan M. Fogelman, Kym F. Faull, Mohamad Navab, Julian P. Whitelegge and Jennifer M. Lang. Their work appears in journals such as American Journal of Obstetrics and Gynecology, Journal of Lipid Research, Proceedings of the National Academy of Sciences, Technology in Cancer Research & Treatment and Biomarker Insights.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact